SAN FRANCISCO, May 14, 2025 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation…Read More

You might also be interested in reading Prop Trading: Instant Funding Acquires Funded Trading Plus.